Skip to content

Dr. Gearóid Tuohy

Ocata Therapeutics Inc., announces enrolment of first patient in embryonic stem cell derived therapy treatment for dry age-related macular degeneration

Ocata Therapeutics Inc. (NASDAQ:OCAT), based in Marlborough, Massachusetts, and formerly known as Advanced Cell Technology Inc., or ACT, have announced the enrollment of their first… Read More »Ocata Therapeutics Inc., announces enrolment of first patient in embryonic stem cell derived therapy treatment for dry age-related macular degeneration